Lifestyle modification in the prevention and treatment of atrial fibrillation.
Autor: | Menezes AR; Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States., Lavie CJ; Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States. Electronic address: clavie@ochsner.org., De Schutter A; Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States., Milani RV; Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States., O'Keefe J; Mid America Heart Institute, Kansas City, MI, United States., DiNicolantonio JJ; Mid America Heart Institute, Kansas City, MI, United States., Morin DP; Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States., Abi-Samra FM; Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, United States. |
---|---|
Jazyk: | angličtina |
Zdroj: | Progress in cardiovascular diseases [Prog Cardiovasc Dis] 2015 Sep-Oct; Vol. 58 (2), pp. 117-25. Date of Electronic Publication: 2015 Jul 13. |
DOI: | 10.1016/j.pcad.2015.07.001 |
Abstrakt: | Atrial fibrillation (AF) is the most common arrhythmia worldwide and has a significant impact on morbidity and mortality. Additionally, the incidence and prevalence of AF is expected to increase in the United States and worldwide over the next few decades. While the pathophysiology concerning the development of AF is not completely understood, multiple modifiable, as well as non-modifiable risk factors, for AF development have been discovered. The goal of this paper is to provide an overview of the modifiable risk factors that contribute to the development and recurrence of AF, in addition to discussing potential lifestyle changes that may aid in the prevention and treatment of AF. (Copyright © 2015 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |